Alniche Lifesciences

Alniche Lifesciences

A Specialty Focused and Fast-Growing Pharma Company

Established in 2007, Alniche Lifesciences is one of India’s leading pharmaceutical companies. It is a specialty healthcare company focused on discovering, developing, and commercializing innovative pharmaceutical products for enabling people to live life to its maximum potential.

Based on the strong foundation of uplifting the Indian healthcare system and improving the lives of individuals with the utmost healthcare offerings, the company has become a reputed brand in over a decade. Initially, the company started with limited resources and investments. Steadily, Alniche expanded its horizons by creating a robust portfolio with innovative technologies and products both domestic and licensed from global partners. This portfolio focuses and fulfills the major requirements of patients in the areas of Nephrology, Critical Care, Gastroenterology, Skinceuticals, Advanced Wound Care, and Neuro-Psychiatry. In a decade, Alniche has marked its presence with a meaningful impact and is one of the fastest-growing pharma enterprises in India.

The Driving Force

A visionary leader, Girish Arora is the Founder and Managing Director of Alniche Lifesciences. He is a self-made man staying true to his roots of hard work and perseverance with a fearless attitude, risk-taking, and resourceful personality. During the initial days of his career, he started working as a marketing professional and toiled for long hours to accomplish career targets with his principled work ethical approach. This accelerated his professional growth and over time, he understood the importance of a customer-centric approach and leveraged strategies to reach the top of the pyramid by heading reputed Pharma companies in India.

More importantly, after working for more than three decades in this field, he has handled the highest positions in multiple organizations and established these companies in the segment of nephrology and critical care with his profound experience. These diverse roles have shaped his business acumen and helped him put his steps in launching his business venture. His valuable contributions to the India pharma market include the ideation of Nephrology as a separate niche business segment in the country. Driven by innovation for new products, Girish is among the first in India, who envisaged collaborating with Academia, for new products/formulation with IIT Chennai.

Adding Feathers to the Cap

Endowed with positivity and the capacity to focus distinctively in the right direction, Girish is successfully overriding the challenges of today’s competitive era by expanding its outreach to millions across the globe. His ignited business acumen, an inherent ability to take risks, and his unconventional approach formed the base of his celebrated career that has earned him numerous accolades and recognitions over time.

His exceptional contribution to the field of healthcare has been recognized with various prestigious national and international honors and awards. To name a few of them:

  • Best Organization in Nephrology Drugs & Novel Formulations Award - Business Sphere, New Delhi, India
  • Fastest Growing Brands & Leaders Award - Asia One, Dubai, UAE
  • Excellence in Pharmaceutical Brand Management Award (New Product Launch) by CPhI, Netherlands (India Pharma Awards 2019)
  • Healthcare Elite Award - Business APAC, India
  • Super 30 Companies Award - Silicon Review, New Jersey, USA
  • Noteworthy Biotech & Pharma Company - Business APAC, India
  • Company of the Year 2019- Business Connect, India
  • 10 Companies with the Most Disruptive Innovation by Business Berg, Dublin, Ohio, USA.
  • Pharma CEO of the year – Time2Leap Awards – MSME edition issued by Ministry of Micro, Small and Medium Enterprises India
  • Emerging brand of the year Time2Leap Awards – MSME edition issued by Ministry of Micro, Small and Medium Enterprises India

Young Board of Directors and Exemplary Team of Business Professionals

Girish Arora is supported by a young team of Board of Directors handling their departments efficiently aligning to the overall objective of the organization.

Girish shares “I have all praise for Ritu Hasija (Director - Corporate Affairs) for her continuous support since the inception of Alniche. She has been a contributory key decision-maker, always dedicated towards realizing the organization's goals and objectives”. Today’s highly competitive and fast-changing business environment demands a highly trained mind that takes tough business decisions at a very fast pace. Ritu has impeccable characteristics of an excellent business leader and has enormous leadership strength.

“Our distribution networks are operational across India,” informs Sumit Arora (Director - Logistics and Sales). “Distributing the products throughout the length and breadth of the country is an important factor that determines the success of the company. At Alniche we have painstakingly developed a meticulous distribution network to cater to patients all over India”.

Finance is one of the major pillars of any organization and an essential ingredient to a successful business. “Keeping a close watch on the finance function is very important for the smooth operation of a company” shares Mehak Arora (Director- Planning & Procurement). She further shares that “Procurement leading to optimum inventory management impacts the finance of a company positively as there is always cost associated with high inventory levels”.

Karan Arora (Director – Marketing & International Business) shares “Alniche continuously looks for opportunities to partner with global pharma companies as we firmly believe that strategic focus and a differentiated approach empower the organization”. Hence we are continuously looking for reputed International partners for in-licensing. We also plan to venture into OTC, Direct-to-consumer (DTC), and Medical devices & Consumable verticals. These futuristic strategies will help Alniche to provide the latest products and services, at par with International standards right here in India.

Alniche has achieved numerous benchmarks in its journey and this has been possible because of its dedicated senior leaders who are capable professionals with an exceptional combination of talent, skills, knowledge, and business acumen. The board is well supported by these astute professionals who work as a core team and strive for success.

Jayan C.P. – Chief Executive Officer Shares Alniche seed sown by our MD has taken the shape of a fully branched tree bearing fruits of success. “Under his leadership, the company has witnessed remarkable growth”. In this Journey, we have spread our wings into seven therapy-focused divisions with a professional sales team and built many strong brands in each therapy vertical. The innovative customer-centric ideas and marketing strategies being framed by the team have resulted in crowning Alniche as one the fastest growing Pharma Company in India.

Pravin Naik – Vice President Critical Care & Neuro-Psychiatry informs that “Constant innovation and adapting to changing market dynamics are the factors that position Alniche at a different pedestal and reaching among the top-ranking companies in Critical care vertical”, Alniche is keeping pace with the changing healthcare system in India by expanding the core and allied therapy segments. These initiatives will make the company future-ready and excel in the growing Healthcare market.

Mumtaz Siddique – Vice President Renal Care informs that “In Renal Care, Alniche is at the forefront competing head-to-head with competitors”, hence one of the prime focus is to continuously coach the team and raise their scientific knowledge. With this approach, the company has to lead a force of over 700 employees with successfully launching and establishing new therapy verticals.

Praveen Gautam - Business Head Gastroenterology, informs that “Alniche has adopted admirable strategies which have led to it becoming the fastest-growing company in India shares”. The novel products and aggressive sales strategy have been the two strong pillars to ensure that Alniche remains ahead of the competition.

Bishwa Sahoo - Business Head Skinceuticals, shares Alniche is growing not only by business but also by amazing leadership, team development, visibility in the market in terms of its ethics and values as well as career and personal development.

Each of these astute professionals has contributed their expertise and significant performance and steered the boat of the organization to the harbor of success. Supporting and sticking to the company through thick and thin, building trustworthy relationships, and encouraging each member of the team has been the driving force for Alniche.

A Powerful and Holistic Healthcare Brand

Alniche Lifesciences' serves patients and the medical fraternity by offering specialized, high-quality, effective, affordable medicines, and wellness products from around the world. In a short period, it has become a brand entity in the Indian Pharma market through its keen approach, momentous strides, advanced amenities and it continues to achieve three to four folds of growth with each succeeding year. With such a whopping growth rate, it has emerged as a fierce competitor in the Nephrology and Critical Care segment continuing the success story in newly expanded therapy segments. The organization is ranked among the Top Three in Nephrology and The Top Ten in Critical Care, pioneering in Bringing Novel Molecules/Formulations in Renal Care and Critical Care.

“Our focus promotes deep engagement with medical specialists and we make it our business to listen to them closely, together we advance in patient care. We combine this strategic focus with a diversified approach that enables us to follow our new specialty areas where unmet needs are significant”, adds Girish Arora.

Alniche’s Professional Triumphs

To promote the “Make in India” concept and encourage Indian researchers to come up with novel technologies and products, Alniche has formed an R&D alliance with Delhi Pharmaceutical Sciences & Research University (DPSRU) – India’s first Pharmacy University. This affiliation of industry and academia promises to augment further development of new products enabling innovations to meet the medical needs of the Indian population. Additionally, as a part of their professional responsibility, Alniche has instituted awards (Jvalat & Vijayin) to encourage the young researchers for the new research and innovative products and ideas.

Apart from his noteworthy contribution in envisioning “Specialty Focused Organization” in India, Girish is a pioneer in conceptualizing and commercializing many novel product concepts in India to enrich product portfolio, like:

  • Ketoanalogue Range in Sachet Limiting the Intake of Fluid for Patients with Kidney Impairment by Reducing Pill Burden
  • Auxisoda – Enteric-Coated Tablets Preventing GI Irritation
  • Research & Patented Products (Complipro & Ezepro – Ready-To-Drink Protein Formula) in Collaboration with DPSRU. These Products Are Launched by Shri Anil Baijal (Honorable Lieutenant Governor of Delhi, Govt. of N.C.T.)
  • Wetfast MD – Mouth Dissolving Lozenge Reducing the Overload of Fluid in CKD Patients
  • Entasafe – a Unique Combination of Pre-Probiotics & Minerals to Control the Adverse Effects of Long-Term Use of PPIs

Innovate and Expand with Changing Market Dynamics

Alniche has responded to the COVID-19 pandemic with its wide and exclusive Critical Care range which includes COVID-19 treatment, supportive and Immunity booster therapies. CurCutop tablets (Patented Immunity booster), Vitamin C injection, Ulinastatin injections, Thymosin Alpha 1 injections, Glutathione injection, Favipiravir tablets, and Remdesivir injection are such examples.

One of the noteworthy achievements in this year, is the introduction of NIZRAL, a Global brand of Ketoconazole shampoo solution, mentioned in most of the medical textbooks with a clinical legacy of 35 years. Alniche has been chosen as a marketing partner by Jansen and Alliance Pharma, UK. NIZRAL will bring us in a different league in the Derma market in India and selected South-Asian markets.

Navigate As per Customers’ Requirements

With changing dynamics of brand promotion, Alniche has enhanced its efforts to promote its brands by employing various digital media techniques like email marketing, Web Posters, and disease-specific promotion on Facebook, Twitter, and LinkedIn.

Alniche launched an online healthcare journal, “Healthcare e-compendium”. This is a joint initiative of DRSC (Doctors’ Scientific Resource for Continuous Education) and DPSRU. DRSC is supported by Alniche. DRSC will support HCPs to share their research, Case studies, and review articles in various medical journals. It’s a service that all HCPs can avail and the DRSC team will support them for their scientific initiatives.

Supporting HCPs and Patients - Timely Delivery of Medicines

To augment the government’s effort in the current pandemic, Alniche has introduced a wide range of products for Covid-19 patients and supplied to COVID-19 hospitals in both the private and government sectors. Alniche is now engaged with various authorities to initiate clinical studies for newer COVID-19 medicines.

To provide an uninterrupted supply of medicines. Alniche has launched a dedicated

24X7 customer helpline 1800 572 2011


R&D: The Yin & Yan in the Pharmaceutical Industry

For any Life Sciences organization, R&D is a fundamental aspect as excellent research and development (R&D) is crucial to the long-term success of the pharmaceutical industry and the wider life-sciences sector. 10% of its profits are spent on new formulation development and R&D initiatives. The key objective here is to develop effective formulations not only for diseases that are prevalent globally but also for diseases that are specific to India and other tropical countries, thus contributing towards the creation of a healthier India and a healthier world.

For Alniche, the quality factor is of paramount importance and hence all the manufacturers are certified with ISO, WHO-GMP, and CGMP certifications. Each product undergoes stringent testing during the manufacturing process, leaving no room for quality grievance. The company has its own Medical and Pharmacovigilance department that is engaged in PMS and coordination with manufacturers to ensure quality compliance.

The Pharmaceutical Market Thrives for a Noble Cause

The inception of Alniche is aimed at serving the needs of Indian patients’ and to provide specialized, high quality, effective, affordable, and value-for-money medicines, and wellness products in India.

Over the years, the Healthcare Industry in India has undergone a paradigm shift and continues to be on a high growth trajectory. In the upcoming times, the industry is projected to grow to $372 bn by 2022, fueled by rising income levels, increasing lifestyle diseases, greater health awareness, improving access to healthcare services and insurance, and government policies promoting effective healthcare for its citizens. The government’s expenditure on the health sector has planned to reach 2.5 % of the country's GDP by 2025.

The pharmaceutical industry has been the main pillar supporting the growth of the healthcare industry in India, while also serving global demand. India’s domestic pharmaceutical market turnover reached $18.12 bn in 2018, growing 9.4% year-on-year. In addition to fulfilling the domestic market demand at affordable prices, the Indian pharmaceutical industry is also one of the largest suppliers of generic drugs globally, exporting to more than 200 countries.

India contributes the second-largest share of the pharmaceutical and biotech workforce in the world. The pharmaceutical industry has thus played a key role in lowering the disease burden in India and enabling better health outcomes across the world through its affordable and high-quality generics drugs. This has been made possible through the entrepreneurial spirit, high-quality talent base for the research-based industry, cost-optimized operations, and above all a service mindset to contribute to the noble cause of alleviating human suffering.

Surpassing Competition with “Out-Of-The-Box” Facilities

Girish has spearheaded Alniche to a unique position among the competitors with his in-depth domain expertise acquired from his forefront professional journey. By integrating the right marketing strategy with a remarkable set of portfolios and approaching the specific target audience is the strategy of the company. A well-designed scientific marketing strategy to repetitively engage with the doctors keeps the company ahead of its competitors. This involves various programs like organizing CMEs, symposia, web hosting, Tele-consultations, disease info & management, advocacy development, newsrooms, latest in therapeutic regimen - book release, practice support, and decision enhancement tools and few others. Each therapy is promoted by a different team, thus bringing the required positioning focus with minimal overlap.

Following this philosophy, Girish and his business development team keeps on looking for new avenues of growth and opportunities to collaborate with global pharma companies. Strengthening the product portfolio is one of the key strategies that sails the organization ahead of its competitors. The prime focus is to enrich each therapy area with unique products that have the scientific backup and can augment the philosophy of end-to-end treatment. In the upcoming times, the company envisions expanding market share in existing therapies, launching new therapy, and allied healthcare units, and making Alniche One of the Top 50 Pharma Companies in India.